rotation.to
Following this device: dark.
Free account
rotation.to
Sign in / Request free access
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Francis Lo

Chief People Officer

Company insider

Files Form 4 as: Chief People Officer, Adaptive Biotechnologies.

Every Form 4 they filed

In numbers

Trades disclosed
226
Buys
1
Sells
32
Bought
$50K
Sold
$28.1M
Companies
1
Companies where not an officer
0
First trade
1 Jul 2019
Last trade
1 Oct 2026
Last filed
5 Oct 2026

Companies traded

Where they are an officer
ADPT Adaptive BiotechnologiesOfficer · Diagnostics & Labs · last 1 Oct 20261 buy · 32 sells

Activity over time

1 Nov 2024 – 1 Oct 2026
40Nov 24May 25Nov 25Apr 26Oct 26

Buys above the line, sells below, each month.

Every trade

TradedCompanyWhatAmount
1 Oct 2026filed 5 Oct 2026ADPT Adaptive BiotechnologiesDiagnostics & LabsSEC FORM 4 Code M$68K8,038 at $8.46filing
1 Oct 2026filed 5 Oct 2026ADPT Adaptive BiotechnologiesDiagnostics & LabsSEC FORM 4 Code M$37K9,377 at $3.99filing
1 Oct 2026filed 5 Oct 2026ADPT Adaptive BiotechnologiesDiagnostics & LabsSEC FORM 4 Code M$76K9,377 at $8.12filing
1 Oct 2026filed 5 Oct 2026ADPT Adaptive BiotechnologiesDiagnostics & LabsSEC FORM 4 Sold$223K8,094 at $27.52filing
1 Oct 2026filed 5 Oct 2026ADPT Adaptive BiotechnologiesDiagnostics & LabsSEC FORM 4 Sold$535K18,698 at $28.61filing
1 Oct 2026filed 5 Oct 2026ADPT Adaptive Biotechnologiesoption or derivative · Diagnostics & LabsSEC FORM 4 Code M—8,038 at $0.00filing
1 Oct 2026filed 5 Oct 2026ADPT Adaptive Biotechnologiesoption or derivative · Diagnostics & LabsSEC FORM 4 Code M—9,377 at $0.00filing
1 Oct 2026filed 5 Oct 2026ADPT Adaptive Biotechnologiesoption or derivative · Diagnostics & LabsSEC FORM 4 Code M—9,377 at $0.00filing
16 Sep 2026filed 18 Sep 2026ADPT Adaptive BiotechnologiesDiagnostics & LabsSEC FORM 4 Code M$645K53,091 at $12.14filing
16 Sep 2026filed 18 Sep 2026ADPT Adaptive Biotechnologiesoption or derivative · Diagnostics & LabsSEC FORM 4 Code M—23,442 at $0.00filing
16 Sep 2026filed 18 Sep 2026ADPT Adaptive BiotechnologiesDiagnostics & LabsSEC FORM 4 Code M$113K13,398 at $8.46filing
16 Sep 2026filed 18 Sep 2026ADPT Adaptive BiotechnologiesDiagnostics & LabsSEC FORM 4 Code M$62K15,629 at $3.99filing
16 Sep 2026filed 18 Sep 2026ADPT Adaptive Biotechnologiesoption or derivative · Diagnostics & LabsSEC FORM 4 Code M—53,091 at $0.00filing
16 Sep 2026filed 18 Sep 2026ADPT Adaptive Biotechnologiesoption or derivative · Diagnostics & LabsSEC FORM 4 Code M—13,398 at $0.00filing
16 Sep 2026filed 18 Sep 2026ADPT Adaptive Biotechnologiesoption or derivative · Diagnostics & LabsSEC FORM 4 Code M—15,629 at $0.00filing
16 Sep 2026filed 18 Sep 2026ADPT Adaptive Biotechnologiesoption or derivative · Diagnostics & LabsSEC FORM 4 Code M—23,442 at $0.00filing
16 Sep 2026filed 18 Sep 2026ADPT Adaptive BiotechnologiesDiagnostics & LabsSEC FORM 4 Code M$190K23,442 at $8.12filing
16 Sep 2026filed 18 Sep 2026ADPT Adaptive BiotechnologiesDiagnostics & LabsSEC FORM 4 Sold$3.0M107,537 at $28.02filing
16 Sep 2026filed 18 Sep 2026ADPT Adaptive BiotechnologiesDiagnostics & LabsSEC FORM 4 Sold$225K7,869 at $28.57filing
16 Sep 2026filed 18 Sep 2026ADPT Adaptive Biotechnologiesoption or derivative · Diagnostics & LabsSEC FORM 4 Code M—53,091 at $0.00filing

News

Adaptive Biotechnologies (NASDAQ:ADPT) COO Sells 11,881 Shares of Company StockADPT · dailypolitical.com · 21 Oct 2026

0 headlines in the last 90 days name Francis Lo; 1 article from the last 14 days about the 1 company they traded most, at most three about any one of them.

Sectors

Health Care33

Buys in green, sells in red, by the company’s sector.

Related people

Julie RubinsteinPresident and COO · President and COO at Adaptive Biotechnologies, filing Form 4 there in the last year
Susan BobulskyChief Commercial Officer, MRD · Chief Commercial Officer, MRD at Adaptive Biotechnologies, filing Form 4 there in the last year
Katey Einterz OwenDirector · Director at Adaptive Biotechnologies, filing Form 4 there in the last year
Robert HershbergDirector · Director at Adaptive Biotechnologies, filing Form 4 there in the last year
Chad M. RobinsCEO and Chairman · CEO and Chairman at Adaptive Biotechnologies, filing Form 4 there in the last year
Peter M. NeupertDirector · Also traded ADPT in the last 90 days